News

Avidity (RNA) Jumps 9.2% on Drug Candidate’s Breakthrough Therapy Designation
Avidity Biosciences saw its share prices increase by 9.21 percent on Friday to end at $36.27 apiece as investor sentiment was bolstered by the Food and Drug Administration’s (FDA) breakthrough ...
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...
Armistice Capital, RTW Investments, and Wellington Management Build Stakes in Rare Disease Therapeutics Sector
Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...
Becker's Hospital Review1d
10 spine innovations earning FDA nods
From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.
MIT Technology Review1d
The Download: saving the US climate programs, and America’s AI protections are under threat
Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...
Inventor claims bleach injections will destroy cancer tumors
Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...
Fudzilla2d
Elsa AI rollout at US FDA sparks chaos
Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...
An Inventor Is Injecting Bleach Into Cancerous Tumors—and Wants to Bring the Treatment to the US
A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...
Corcept (CORT) Advances Ovarian Cancer Therapy with FDA Filing for Relacorilant
Corcept Therapeutics Incorporated (NASDAQ: CORT) is one of the growth stocks that could double by 2027. On July 14, CORT ...
Que.com on MSN2d
AI in FDA Drug Approvals Sparks Controversy Over Fabricated Studies
In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...
The FDA Is Using an AI to "Speed Up" Drug Approvals and Insiders Say It's Making Horrible Mistakes
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...
FDA’s AI tool “hallucinates confidently.”
U.S. Food and Drug Administration employees told CNN that Elsa — the AI model that’s supposed to help speed up approvals of pharmaceuticals and medical devices — isn’t working great. Instead, it cites ...